PALOZEST 0.25MG/5ML INJECTION

Content Reviewed By:

Written By:

• PALOZEST 0.25MG/5ML INJECTION is a medication containing palonosetron, an isoquinoline derivative that functions as a 5-HT3 receptor antagonist. This means it effectively blocks the action of serotonin, a naturally occurring substance in the body that can trigger nausea and vomiting. By preventing serotonin from binding to its receptors, PALOZEST 0.25MG/5ML INJECTION significantly reduces the likelihood and severity of these unpleasant side effects.
• This medication is particularly valuable for individuals undergoing cancer treatment, specifically chemotherapy and radiation therapy. These treatments often cause significant nausea and vomiting, known as chemotherapy-induced nausea and vomiting (CINV) and radiation-induced nausea and vomiting (RINV), respectively. PALOZEST 0.25MG/5ML INJECTION is highly effective in preventing and treating these conditions, improving the patient's overall comfort and quality of life during treatment.
• Furthermore, PALOZEST 0.25MG/5ML INJECTION's efficacy extends to patients receiving radiation therapy to the whole body or abdomen, areas particularly prone to inducing nausea and vomiting. Its targeted action on serotonin receptors makes it a reliable and well-tolerated option for managing these side effects, allowing patients to focus on their recovery and treatment progress without the debilitating effects of nausea and vomiting.

• PALOZEST 0.25MG/5ML INJECTION will be administered to you by a qualified healthcare professional in a hospital or clinical setting. This ensures the medication is given safely and effectively. The injection will be administered intravenously, meaning it will be injected directly into a vein, typically in your arm or hand. It is crucial that you do not attempt to self-administer this medicine.
• The precise dosage of PALOZEST 0.25MG/5ML INJECTION will be determined by your doctor, taking into account your specific medical condition, your response to treatment, and other relevant factors. This personalized approach ensures you receive the optimal dose for your needs.
• Typically, PALOZEST 0.25MG/5ML INJECTION is administered approximately 30 minutes before you receive your chemotherapy treatment or immediately before anesthesia for a surgical procedure. This timing helps to prevent nausea and vomiting associated with these medical interventions.
• If you are prescribed palonosetron in oral tablet form, it is important to swallow the tablet whole with a glass of water. You can take it with or without food, as directed by your healthcare provider. To ensure the medication is absorbed properly, avoid crushing, chewing, or breaking the tablet before swallowing.